Pharmacokinetics and Safety of Ezetimibe/Simvastatin Combination TabletAn Open-Label, Single-Dose Study in Healthy Chinese Subjects

被引：0
|
作者：
Nan-Nan Chu
Wei-Li Chen
Hong-Rong Xu
Xue-Ning Li
机构：
[1] Fudan University,Department of Clinical Pharmacology, ZhongShan Hospital
来源：
Clinical Drug Investigation | 2012年 / 32卷
关键词：
Simvastatin; Ezetimibe; Combination Tablet; Simvastatin Acid; Healthy Chinese Subject;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：791 / 798
页数：7
相关论文
共 50 条
  • [1] Pharmacokinetics and Safety of Ezetimibe/Simvastatin Combination Tablet An Open-Label, Single-Dose Study in Healthy Chinese Subjects
    Chu, Nan-Nan
    Chen, Wei-Li
    Xu, Hong-Rong
    Li, Xue-Ning
    CLINICAL DRUG INVESTIGATION, 2012, 32 (12) : 791 - 798
  • [2] Pharmacokinetics, safety, and tolerability of sulcardine sulfate: an open-label, single-dose, randomized study in healthy Chinese subjects
    Chen, Qian
    Qian, Hong-jie
    Wang, Wei
    Zhang, Meng-qi
    Lu, Dong-ying
    Lu, Chuan
    Jin, Jie-mei
    Hu, Chao-ying
    Liu, Gang-yi
    Jia, Jing-ying
    Zheng, Hong-chao
    Li, Xue-ning
    Yu, Chen
    Wang, Yi-ping
    Liu, Yun
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (01) : 120 - 125
  • [3] Pharmacokinetics and Bioequivalence of Fixed-Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open-Label Study in Healthy Volunteers
    Leong, Chuei Wuei
    Yee, Kar Ming
    Rani, Tracy Ann
    Lau, Kheng Jinm
    Ahmad, Shahnun
    Amran, Atiqah
    Hassan, Farah Wahidah Mohd
    Kumar, Naveen
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (08): : 938 - 946
  • [4] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Trivedi, Ashit
    Mather, Omar
    Vega, Silvia
    Hutton, Shauna
    Hellawell, Jennifer
    Lee, Edward
    DRUGS IN R&D, 2022, 22 (02) : 141 - 146
  • [5] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Ashit Trivedi
    Omar Mather
    Silvia Vega
    Shauna Hutton
    Jennifer Hellawell
    Edward Lee
    Drugs in R&D, 2022, 22 : 141 - 146
  • [6] Pharmacokinetics and tolerability of intravenous posaconazole in healthy Chinese volunteers: a randomized, open-label and single-dose study
    Ji, Wei
    Zhao, Hengli
    Yang, Shaomei
    Wen, Qing
    He, Kun
    PHARMAZIE, 2020, 75 (10): : 491 - 493
  • [7] Pharmacokinetics of oral viaminate in healthy Chinese subjects: an open-label, sequential, single-dose, food-effect, and multiple-dose study
    Li, Lingjun
    Shen, Yue
    Ma, Pengcheng
    Tao, Lei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11639 - 11644
  • [8] Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study
    Cao, Guoying
    Yang, Haijing
    Wang, Jingjing
    Ishida, Masahiro
    Thoma, Christian
    Haeufel, Thomas
    Bossert, Sebastian
    Zhang, Jing
    ADVANCES IN THERAPY, 2024, 41 (09) : 3557 - 3568
  • [9] Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open-Label, Randomized, Single-dose, Crossover Study With Healthy Chinese Volunteers
    Wang, Shumin
    Wu, Feng
    Han, Ying
    Ni, Siyang
    Guo, Shaojie
    Dai, Yuyang
    Xia, Qiang
    Chang, Di
    Zhang, Ju
    Wei, Huiwen
    Zhao, Xiuli
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (08): : 949 - 956
  • [10] Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Canagliflozin in Healthy Chinese Subjects
    Chen, Xia
    Hu, Pei
    Vaccaro, Nicole
    Polidori, David
    Curtin, Christopher R.
    Stieltjes, Hans
    Sha, Sue
    Weiner, Sveta
    Devineni, Damayanthi
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1483 - 1492
12345